• Profile
Close

Effect of long-lasting insecticidal nets with and without piperonyl butoxide on malaria indicators in Uganda (LLINEUP): A pragmatic, cluster- randomized trial embedded in a national LLIN distribution campaign

The Lancet Apr 22, 2020

Staedke SG, Gonahasa S, Dorsey G, et al. - In Uganda's national long-lasting insecticidal nets (LLINs) campaign, a pragmatic cluster-randomized trial was embedded with the aim to compare conventional LLINs with those containing piperonyl butoxide (PBO), a synergist that can partially restore pyrethroid susceptibility in mosquito vectors. Researchers performed random assignment of 104 health sub-districts, from 48 districts in Uganda, to LLINs with PBO (PermaNet 3.0 and Olyset Plus) and conventional LLINs (PermaNet 2.0 and Olyset Net). From March 25, 2017, to March 18, 2018, they randomly allocated 32 clusters to PermaNet 3.0, 20 to Olyset Plus, 37 to PermaNet 2.0, and 15 to Olyset Net. In the as-treated analysis, exclusion of three clusters was performed as no dominant LLIN was received, and reassignment of four clusters was performed, resulting in 49 PBO LLIN clusters (31 received PermaNet 3.0 and 18 received Olyset Plus) and 52 non-PBO LLIN clusters (39 received PermaNet 2.0 and 13 received Olyset Net). Cross-sectional surveys were conducted at baseline 6, 12, and 18 months after LLIN distribution in 50 randomly selected households per cluster (5,200 per survey); a subset of 10 households per cluster (1,040 per survey) were randomly selected for entomological surveys. Outcomes suggested more effective reduction of parasite prevalence in Uganda, where pyrethroid resistance is high, in correlation with using PBO LLINs vs conventional LLINs for up to 18 months. Evidence was thus gained in support of WHO's final recommendation on use of PBO LLINs.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay